Gavestinel sodium
Gavestinel sodium is an orally active, potent, and selective noncompetitive NMDA receptor antagonist targeting the glycine site with a pKi of 8.5. It has been investigated in clinical studies for acute ischemic stroke and is used in research to study excitotoxicity in both in vitro and in vivo models of neurological injury.
Product Specifications
CAS Number
153436-38-5
Product Name Alternative
NMDA receptor, GV 150526, GV 150526A, GV150526, GV-150526, iGluR, Gavestinel, Gavestinel sodium, Gavestinel sodium salt
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
99.04% (May vary between batches)
Solubility
DMSO:90 mg/mL (226.59 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (8.31 mM)
Smiles
O=C (NC1=CC=CC=C1) /C=C/C2=C (C ([O-]) =O) NC3=CC (Cl) =CC (Cl) =C23.[Na+]
Molecular Formula
C18H11Cl2N2NaO3
Molecular Weight
397.19
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Buccutite™ Rapid PE-iFluor® 594 Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 100 ug Antibody Per Reaction*
TIMP2 (Tissue Inhibitor of Metalloproteinase 2) (TIMP2/2488R), CF647 conjugate, 0.1mg/mL
